Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Pediatr Res. 2013 Sep 4;74(6):721–729. doi: 10.1038/pr.2013.162

Table 1.

Baseline Characteristics of Enrolled Infants by Treatment Group

Characteristic Placebo
(N=25)
Inositol
60 mg/Kg
(N=25)
Inositol
120 mg/Kg
(N=24)
P-value
Gestational Age (weeks) Median (range) 26.9 (24.0–29.3) 26.7 (23.7–29.7) 27.1 (23.7–29.7) 0.98
Gestational Age Stratum 27–29 weeks, N (%) 12 (48%) 12 (48%) 13 (54%) 0.88
Birth Weight (g) Median (range) 995 (610–1470) 1020 (640–1340) 968 (690–1495) 0.95
Gender Female, N (%) 12 (48%) 14 (56%) 11 (46%) 0.75
Race, Non-Hispanic White N (%) 11 (44%) 12 (48%) 12 (50%) 0.91
Antenatal steroids N (% yes) 20 (80%) 21 (84%) 20 (83%) 0.92
Chorioamnionitis N (% yes) 8 (32%) 5 (20%) 5 (21%) 0.54
Apgar score, 1 minutea Median (range) 4.5 (1–9) 6.5 (0–9) 6 (1–9) 0.51
Apgar score, 5 minutea Median (range) 7 (4–9) 7 (0–9) 8 (1–9) 0.47
Age (days) at infusion Median (range) 3.2 (1.4–5.2) 3.1 (1.4–5.1) 2.4 (1.4–4.9) 0.22
a

missing Apgar scores: infant born in ambulance (n=1); infant born in Mexico (n=1)